Skip to main content
Premium Trial:

Request an Annual Quote

Case Closed: Sep 5, 2012

The lawsuit between the University of Pennsylvania and Craig Thompson, the CEO of Memorial Sloan-Kettering Cancer Center in New York has been settled, reports Fierce Biotech. As Pharmalot's Ed Silverman recounts, the Abramson Family Cancer Research Institute at UPenn sued Thompson, its former scientific director, for using intellectual property belonging to the school to found Agios Pharmaceuticals. Penn asked for $1 billion in damages, while Thompson denied the charges.

Penn and Agios have settled the suit, and have now announced a new licensing agreement, Fierce Biotech adds. "We are pleased to be moving forward in a collaborative manner around newly identified intellectual property," says Chi Van Dang from the Abramson Cancer Center at Penn in a statement. "We look forward to working with Agios on this project and potentially other unrelated projects in the future."

The Scan

Panel Recommends Pfizer-BioNTech Vaccine for Kids

CNN reports that the US Food and Drug Administration advisory panel has voted in favor of authorizing the Pfizer-BioNTech SARS-CoV-2 vaccine for children between 5 and 11 years old.

Sharing How to Make It

Merck had granted a royalty-free license for its COVID-19 treatment to the Medicines Patent Pool, according to the New York Times.

Bring it Back In

Bloomberg reports that a genetic analysis has tied a cluster of melioidosis cases in the US to a now-recalled aromatherapy spray.

Nucleic Acids Research Papers on SomaMutDB, VThunter, SCovid Databases

In Nucleic Acids Research this week: database of somatic mutations in normal tissue, viral receptor-related expression signatures, and more.